Clinical Trial Update: Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating the combination of sorafenib and bi-weekly capecitabine in patients with metastatic breast cancer and gastrointestinal tumors h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastrointestinal Tumors

Drugs mentioned

• Capecitabine (capecitabine)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Yale University | Conditions: Metastatic Breast Cancer, Gastrointestinal Tumors | Phase 1 | Status: COMPLETED